Clearside Biomedical Inc (NASDAQ:CLSD) Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Jenny Kobin - Head of IR George Lasezkay - President, CEO and Director Tom Ciulla - Chief Medical Officer and Chief Development Officer Charles Deignan - CFO Conference Call Participants Stacy Lee - Stifel Rohit Bhasin - Needham & Company Yi Chen - H.C. Wainwright William Wood - B. Riley Operator Good day, and thank you for standing by. Welcome to the Clearside Biomedical Q2 2022 Financial ...